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particles subsets. The aim of our work was to determine, by analyz-
ing injected solutions, if the misuses of the generics could be more 
dangerous than that of the Subutex®.
Patients (or Materials) and Methods: Injection material used 
was contained in Steribox®II Kit. Solutions were prepared using 
Subutex® 8 mg or buprenorphine 8 mg generic as follows: tablet 
was dissolved in 1 mL of water, mashed with the syringe’s piston, 
and filtered through a cotton pad or a Sterifilt®. Quantification of 
buprenorphine concentration was performed by U-HPLC; particles 
size distribution was performed by laser granulometry and flow 
cytometer.
Results: Seventy percent to 100% of the dose of buprenorphine 
contained in a tablet was found in the solution, whatever the drug 
and the filter used. After filtration with cotton pad, the maximal size 
of the particles found in solution reached 100 µm for the generic 
and 47 µm for Subutex®. With Sterifilt®, the maximal size of the 
particles were 36 µm for the generic and under the limits of the laser 
granulometer for Subutex®. These results were confirmed by flow 
cytometer: after Sterifilt® filtration, more particles > 5 µm were found 
for the generic with regard to the princeps.
Conclusion: Extraction recovery of buprenorphine tablets was excel-
lent and similar for both princeps and generic. These results confirm 
that buprenorphine remains an excellent candidate for misuse. We 
have highlighted the wide variation of the quantity and the size of 
the particles present in solution between the 2 drugs after cotton pad 
filtration. According to these preliminary results, misuse of injected 
buprenorphine could be more dangerous with the generic form than 
with the princeps, in particular in term of thromboembolic events.
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Introduction: Soy products are used in human diet and in food 
additives because of their beneficial effects in menopause and their 
potential protective effects in cancer and other diseases. Nevertheless, 
genistein and other phytoestrogens contained in soy may disrupt the 
endocrine system by modulating the hypothalamic-pituitary-gonadal 
axis, and thus they may influence spermatogenesis and reproduction. 
The objective of this study was to investigate the adverse effects of 
chronic soy diet on the histologic characteristics of the reproductive 
organs in adult male rats.
Patients (or Materials) and Methods: Two groups of adult male 
albino Wistar rats, 6 months old, were used: the study group and the 
control group. The study group received ad libidum food enriched 
in soy protein for 3 months. The control group received ad libidum 
the standard food for 3 months. Both groups were grown under the 
same conditions and according to the rules of Good Laboratory 
Practice. The study was approved by the local ethics committee. 
The animals of both groups were sacrificed, and specimens of the 
reproductive organs were prepared and stained for microscopic 
examination. The preparations were observed by 2 different per-
sons, blinded to the source of the specimen. Statistical analysis was 
performed with the statistical package SPSS.
Results: The seminiferous epithelium of the testes was found lower 
and contained fewer layers of spermatocytes in the study group com-
pared with the control group. Similar changes were observed in the 
epididymidal epithelium and the epithelium of the vas deferens and 
the seminal vesicles of the study group. The number of spermatozoa 
in the seminiferous tubules of the testes, in epididymis, and in the vas 
deferens was much lower in rats fed with soy diet compared with the 
rats fed with standard food.
Conclusion: Chronic soy diet causes histologic changes in the repro-
ductive organs and influences the number of spermatozoa in the testes 
of the adult rats. Diet containing phytoestrogens may influence male 
fertility and should probably be avoided in a chronic basis when 
pregnancy is desired.
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Introduction: Enforcement of new EU Pharmacovigilance (PV) 
Regulation 1235/2010 and Directive 2010/84/EU, in July 2012, 
caused differencies from local PV regulations of some European 
non-EU countries. Consequently, disturbances of PV practices have 
been caused at local affiliates of international pharma companies 
who based their operational procedures on local law aligned with 
EU Legislation.
Patients (or Materials) and Methods: The review and comparison 
of EU PV Legislation and Local PV Regulation of Serbia 64/2011 
were done. Main differences are listed and their impact on local 
PV practice is presented. Local PV regulation of Serbia was chosen 
becaue: (1) authors are from Serbia; and (2) the local regulation is 
more complex than others in the region.
Challenges in local PV practices are presented based on experience 
of Janssen local safety unit (LSU).
Results: Main differences: (1) Pharmacovigilance System Master 
File (PSMF) and Summary of Pharmacovigilance System (SPS) vs. 
Detailed Description of Pharmacovigilance System (DDPS);
(2)Periodicity and timelines for Periodic Safety Update Reports 
(PSUR) submission;
(3)European Risk Management Plan (EU RMP) vs. RMP
(4)Safety reports for renewals: Addendum Clinical Overview 
(ACO) vs. Summary Bridge Report (SBR) and Addendum report (AR).
(1)According to EU legislation, SPS has to be submitted to 
European Medicines Agency and PSMF only in case of explicit 
requirement. According to local requirements, global and local DDPS 
are needed. SPS is not enough. PSMF accepted, but could not be 
requested. Appropriate global document is milestone to be compliant 
and to obtain approval/renewal license.
(2)Locally, periodicity, and timeline for PSUR submission are still 
“old.” However, Local Health Authority (LHA) accepts European 
Union Referens Dates (EURD) list for “centralized products” (CP) 
and for non-CP with renewals. Unevenness requires enhanced moni-
toring of PSUR periodicity and timelines and make compliance dif-
ficult.
(3)Locally, EU RMP is accepted. However, implementation is 
delayed since LHA based approval on EMA approval.
(4)Locally, SBR and AR are required for renewals. LHA tends 
to accept ACO, but currently, only as additional document. 
Consequences are additional effort and cost for Company to prepare 
SBR and AR, and ACO, in addition.
Overall, LHA has not had access to EudraVigilance database, 
and worldwide individual case safety reports have to be submitted 
to LHA by LSU, which is time-consuming.
Clinical Therapeutics
e30 Volume 35 Number 8S
Conclusion: LHA tends to accept EU requirements as much as it 
could match local regulation, but local regulation differs significantly 
from EU. As a consequence, LSU makes additional efforts and com-
munications with LHA and Company, to fulfill each requirement 
in its own way. The differences could be overcome with harmo-
nization of local regulation with EU and if LHA receive access to 
EudraVigilance database.
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Introduction: Medical and pharmaceutical professionals in Serbia 
gather information on drugs from the National Agency of Drugs 
and Medical Devices or from the various publications such as British 
National Fromulary and Physicians Drug Reference. General pop-
ulation can obtain information from their general practitioners 
(GP) or pharmacist. At Department of Pharmacology and Clinical 
Pharmacology, Medical faculty of Novi Sad, there exists a Drug 
Information Unit, regional center offering drug information to both 
professional and general population in Vojvodina (~1,600,000 inhab-
itants).
Patients (or Materials) and Methods: Clients require information 
by telephone (> 99.5% request) or by e-mail. Interns in Clinical 
Pharmacology collect necessary data regarding the therapeutic 
problem (eg, age and sex of the patient, other drugs taken, present 
diseases). After case solving, and upon the approval from the senior 
clinical pharmacologist, interns deliver the information to the client 
(both by telephone and e-mail).
Results: About 3% of all requests are from general population (usu-
ally questions on interactions, side effects, dosing, and administra-
tion). Remaining requests are from health (20% from GPs and 80% 
from specialists) or pharmaceutical professionals. Almost 30% of all 
of the requests of the health professional are regarding possible drug–
drug or drug–disease interactions. About 12% of requests are related 
to side effects of the administered drug. Pregnancy and lactation are 
subjects of interest in 15% of overall number of requests. Maximal 
doses allowed and posology have shares of ~11%. Remaining infor-
mation is concerning the pharmacokinetics of the drug, first-line 
drugs for certain disease, dosing in children, etc.
Conclusion: According to our experience, the Drug Information 
Unit is quite useful source of information for both professionals and 
general population offering various information on different topics 
related to drugs.
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Introduction: Our study assessed the safety of low doses of metha-
done combined with benzodiazepines during first month of metha-
done maintenance treatment (MMT) in opioid addicts, according to 
differences in corrected QT (QTc) interval and side effects.
Patients (or Materials) and Methods: The study included patients 
with a diagnosis of opioid dependence, who were referred to the 
MMT at the Clinic of Psychiatry, Clinical Centre of Vojvodina, Novi 
Sad, during 2012. All patients were interviewed about their age, 
duration of heroin misuse, and the presence of ECG disorders in the 
first-degree relatives. One month after the beginning of MMT, they 
were interviewed about experienced side effects. Data about applied 
methadone dose and the use of benzodiazepines were collected from 
the medical history of each patient. Before the methadone intake for 
the first time and 1 month after the beginning of MMT, all patients 
underwent a 12-lead ECG. The QTc was calculated using Bazett’s 
formula.
Results: A total of 20 patients were enrolled in the study during the 
observed period. Their average age (SD) was 32.21 (5.63) years. 
The average heroin misuse time (SD) was 11.95 (4.02) years. In the 
patients’ history, no cardiovascular diseases were reported, as well as 
sudden cardiac death or family history of long QTc in the first-degree 
relatives. A statistically significant increase (P < 0.05) in the length 
of QTc intervals measured after 1 month of MMT (QTc1) in com-
parison with those at the baseline (QTc0) was observed. The mean 
(SD) methadone dose was 45.26 (15.41) mg. The most frequently 
used drug in combination with methadone was diazepam, which 
was used in 85% of patients. The mean dose (SD) of diazepam was 
30.93 (10.36) mg. A statistically significant dose-dependent correla-
tion between concomitantly used diazepam daily dose and QTc1 
(R2 = 0.47, P = 0.008) was revealed, but without a statistically sig-
nificant dose-dependent correlation between methadone and QTc1 
(P = 0.960). The most commonly reported side effects were sweating 
(65%), obstipation (60%), and itch (55%). None of participants 
experienced any cardiac side effects.
Conclusion: With respect to the results, it would be advisable to 
perform both pretreatment and regular ECG checkup after 1 month 
of MMT, especially in case of concomitant use of benzodiazepines.
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Introduction: According to the recommendations of the World 
Health Organization, ergot alkaloids are neither the drug of first 
choice for the induction of the labor and not for the treatment of the 
postpartum hemorrhage because of their harmful side effects. The 
objective of this research was to follow the influence of the educa-
